Barbosa Ma Elisa Martínez, Bouteiller Laurent, Cammas-Marion Sandrine, Montembault Véronique, Fontaine Laurent, Ponchel Gilles
UMR CNRS 8612, Laboratoire de Pharmacotechnie et Biopharmacie, Faculté de Pharmacie, Université Paris-Sud, 5 rue J. B. Clément, 92290 Châtenay-Malabry, France.
J Mol Recognit. 2008 May-Jun;21(3):169-78. doi: 10.1002/jmr.882.
Imparting desired technological characteristics to polymeric nanoparticles requires the development of original polymers. In the present work, the synthesis and characterization of a novel PBLG-derivative, the poly(gamma-benzyl L-glutamate)-beta-cyclodextrin (PBLG-beta-CD-50), have been carried out. Nanoparticles from either PBLG-beta-CD-50 polymer or from mixtures with PBLG have been prepared using a modified nanoprecipitation method. Spherically shaped nanoparticles with diameter in the range of 50-70 nm were obtained, as determined by dynamic laser light scattering and transmission electron microscopy. The presence of a surfactant in the suspension medium had almost no influence on these parameters and was not necessary to the shelf-stability of the suspension. Further, isothermal titration microcalorimetry (ITC) experiments have been used to show unambiguously that about 20% of the cyclodextrins remain functional within the particles. Consequently, this system may be of interest when association of large amounts of hydrophobic drugs to nanoparticles is required.
赋予聚合物纳米颗粒所需的技术特性需要开发新型聚合物。在本工作中,已开展了一种新型聚γ-苄基-L-谷氨酸酯衍生物——聚(γ-苄基-L-谷氨酸酯)-β-环糊精(PBLG-β-CD-50)的合成与表征。使用改良的纳米沉淀法制备了由PBLG-β-CD-50聚合物或其与PBLG的混合物形成的纳米颗粒。通过动态激光光散射和透射电子显微镜测定,得到了直径在50-70nm范围内的球形纳米颗粒。悬浮介质中表面活性剂的存在对这些参数几乎没有影响,并且对于悬浮液的储存稳定性不是必需的。此外,等温滴定量热法(ITC)实验已明确表明,约20%的环糊精在颗粒内仍保持功能。因此,当需要将大量疏水性药物与纳米颗粒结合时,该系统可能会受到关注。